
Mile Brujic, OD, FAAO, speaks on the power of Rinsada to bust biofilms at Vision Expo East 2024.

Mile Brujic, OD, FAAO, speaks on the power of Rinsada to bust biofilms at Vision Expo East 2024.

The new model features stray light shielding, active micro-lens optics, improved power efficiency, and a scalable platform.

According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.

The transient receptor potential melastatin 8 (TRPM8) are cold-sensitive thermoreceptors that play central role in tear film homeostasis.

Prevent Blindness and the American Optometric Association have released resources and educational information to help the public and eye care providers prepare for the astronomical event on April 8.

Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.

How eye care practices and doctors can prepare for the next pandemic

Professor and chief of low vision rehabilitation service Patrick D. Yoshinaga, OD, MPH, FAAO, chats with Dr Korik about assistive tech, AI, and accessibility for patients with low vision.

The new Focused inSights report tracks trends in eyeglasses frames preferences, with factors such as sustainability, technology, and online versus in-person shopping impacting purchasing habits.

This year’s conference, held from March 14-17, will be its last in New York City.

The online eyewear retailer has partnered with Meta, US Vision, and PPG through its new Zenni Business platform.

Building confidence and knowledge can reduce office visits and increase results.

LL-BMT1 is a novel, preservative-free, weekly drug-eluting contact lens created by the company’s proprietary 3D printing technology.

The lens technology was found to have improved headache symptoms.

A travel in time and across the world shows the development of refractive surgery and how eye care providers can play a part in the future of pre- and postoperative refractive surgery care.

Catch up on what happened in optometry during the week of March 4-March 8.

Horace Deal, OD, will serve a 2024-2025 term and brings nearly 30 years of optometric experience to the position.

Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them.

The Vision Council's CEO Ashley Mills previews a nostalgic year for Vision Expo East, as it celebrates and looks back on almost 40 years in New York.

The South Korean study found that those with age-related macular degeneration may be more at risk of developing some cancers, like renal and thyroid.

Marc R Bloomenstein, OD, FAAO, chats with Optometry Times on the benefits of using Vevye to treat dry eye disease, when to prescribe, and how to distinguish quality candidates.

Switching produced an additional 25% IOP reduction in mild-to-moderate OAG and OHT.

The approval marks the first new steroid on the ophthalmic market in more than 15 years.

Ferroptosis is a form of cell death that depends on the presence of iron in the cells.

Eric Fazio, OD, sits down with Optometry Times to weigh the pros and cons of EVO ICLs and LASIK and the role comanagement plays in the decision.

The new prescription lens series, which transition faster while keeping out UVA and UVB rays, will be available in April 2024.

Catch up on what happened in optometry during the week of February 26-March 1.

The authors suggested genetic mutation may relax the body’s defenses and allow harmful bacteria to reach the eye.

Barry Eiden, OD, FAAO, FSLS, sits down with Optometry Times to highlight the importance of staying up-to-date with technology in the development of treatment and diagnosis of keratoconus and what's to come at this year's IKA Keratoconus Symposium in May.

Second annual meeting builds upon firm foundation to enhance education.